Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies

被引：0
|
作者：
El Darsa, Haidar [1 ,2 ]
Massoud, Radwan [1 ,2 ]
Zahreddine, Ammar [1 ,2 ]
Bazarbachi, Ali [1 ,2 ]
El-Cheikh, Jean [1 ,2 ]
机构：
[1] Amer Univ Beirut, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Dept Internal Med, Div Hematol & Oncol, Beirut, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RES-133
引用
收藏
页码：S390 / S391
页数：2
相关论文
共 50 条
  • [41] INTENSIVE PREPARATIVE REGIMEN EMPLOYING BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL BODY IRRADIATION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELOID MALIGNANCIES
    Yano, S.
    Usui, N.
    Dobashi, N.
    Yahagi, Y.
    Takei, Y.
    Sugiyama, K.
    Ogasawara, Y.
    Takahara, S.
    Yamaguchi, Y.
    Saito, T.
    Okawa, Y.
    Minami, J.
    Yokoyama, H.
    Kohayashi, T.
    Otsubo, H.
    Hoshi, Y.
    Asai, O.
    Aiba, K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 108 - 108
  • [42] Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Mates, M
    Michalska, H
    Hasegawa, W
    Kiss, T
    Daly, A
    Loach, D
    Messner, H
    Lipton, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 36 - 36
  • [43] Allogeneic stem cell transplantation with 3-days busulfan plus fludarabine as conditioning regimen for patients with relapsed or refractory t- and nk/t-cell lymphomas
    Lee, J. H.
    Yang, D. -H.
    Jo, J. -C.
    Lee, Y. J.
    Lee, W. -S.
    Choi, Y. S.
    Moon, J. H.
    Do, Y. R.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 159 - 160
  • [44] Efficacy and safety of cladribine in combination with busulfan and cyclophosphamide as an intensive conditioning regimen preceding allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia
    Xiao, Fang
    Guo, Huanxu
    Yan, Xueqian
    Qi, Meiying
    Zhang, Jingyi
    TRANSPLANT IMMUNOLOGY, 2024, 84
  • [45] Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide
    Lee, S. H.
    Cheuh, H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S139 - S139
  • [46] Fludarabine/Cyclophosphamide/Rituxan is an effective regimen for non-myeloablative allogeneic stem cell transplantation (SCT) for lymphoid malignancies.
    Berkahn, LC
    Simpson, DR
    Raptis, A
    Klingemann, HG
    BLOOD, 2000, 96 (11) : 352B - 352B
  • [47] Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
    Jiang, Jieling
    Li, Xiaofan
    Wu, Dong
    Lu, Quanyi
    Miao, Kourong
    Wang, Houcai
    Li, Xiaoping
    Chen, Yingnian
    Zhou, Shiyuan
    Zhou, Yali
    Liao, Guiping
    Jiang, Chuanhe
    Yuan, Xiaohong
    Zhao, Youshan
    Chang, Chunkang
    Chen, Jie
    Zhu, Han
    Ma, Ruye
    Li, Nainong
    Yin, Xiaolin
    Wu, Xiaojin
    Wang, Sanbin
    Wang, Chun
    Hu, Jiong
    EJHAEM, 2024, 5 (04): : 757 - 767
  • [48] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation
    Anne Banet
    Ali Bazarbachi
    Myriam Labopin
    Nicolas Stocker
    Rémy Duléry
    Florent Malard
    Zoé Van de Wyngaert
    Alexis Genthon
    Mara Memoli
    Ollivier Legrand
    Agnes Bonnin
    Tounes Ledraa
    Ramdane Belhocine
    Simona Sestili
    Jean El-Cheikh
    Mohamad Mohty
    Eolia Brissot
    Bone Marrow Transplantation, 2023, 58 : 61 - 67
  • [49] Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies
    Kennedy, Vanessa E.
    Savani, Bipin N.
    Greer, John P.
    Kassim, Adetola A.
    Engelhardt, Brian G.
    Goodman, Stacey A.
    Sengsayadeth, Salyka
    Chinratanalab, Wichai
    Jagasia, Madan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1801 - 1807
  • [50] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation
    Banet, Anne
    Bazarbachi, Ali
    Labopin, Myriam
    Stocker, Nicolas
    Dulery, Remy
    Malard, Florent
    Van de Wyngaert, Zoe
    Genthon, Alexis
    Memoli, Mara
    Legrand, Ollivier
    Bonnin, Agnes
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    El-Cheikh, Jean
    Mohty, Mohamad
    Brissot, Eolia
    BONE MARROW TRANSPLANTATION, 2023, 58 (01) : 61 - 67
12345